Fritextsökning
Innehållstyper
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Printing sensors for biological samples
Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.
-
Framåt för Sobi
Efter gårdagens kvartalsrapport som slog förväntningarna får bolagets läkemedel Alprolix godkänt i Schweiz.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Nytt potensmedel testas i Uppsala
Buskväxt gav upphov till långtidsverkande effekt på sexuell förmåga.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Astrazeneca säljer lokaler
Efter de senaste omorganisationerna minskar behovet av kontoret.
-
Bioinvent tankar kassan
Tar in totalt 64 miljoner kronor genom en företrädesemission och en riktad emission.
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
Annika Garnås, LAB
Why are you going to Scanlab+Biotech Forum?
-
Pronova Biopharma grows
Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Startskott för blödarstudie
Nu doseras första patienten i fas II/III-studien med Sobis och Biogenidecs läkemedelskandidat mot blödarsjuka.
-
Ökad vinst för Moberg Pharma
Den ökade försäljningen drar upp resultaten i det andra kvartalet.
-
SK Pumpen – en torrslampump för avvattnat slam | AxFlow AB
Torrslampump - ett nytt sätt att flytta avvattnat slam från av vattenanordningarna till deponi.
-
Dako appoints new CEO
The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
BREAKING